Active targeting of nanostructures containing chemotherapeutic agents can improve
cancer treatment. Here, a three-way junction pocket
DNA nanostructure was developed for efficient
doxorubicin (Dox) delivery into
cancer cells. The three-way junction pocket
DNA nanostructure is composed of three strands of
AS1411 aptamer as both a therapeutic aptamer and
nucleolin target, the potential
biomarker of prostate (PC-3 cells) and breast (4T1 cells)
cancers. The properties of the Dox-loaded three-way junction pocket
DNA nanostructure were characterized and verified to have several advantages, including high serum stability and a pH-responsive property. Cellular uptake studies showed that the Dox-loaded
DNA nanostructure was preferably internalized into target
cancer cells (PC-3 and 4T1 cells). MTT cell viability assay demonstrated that the Dox-loaded
DNA nanostructure had significantly higher cytotoxicity for PC-3 and 4T1 cells compared to that of nontarget cells (CHO cells, Chinese hamster ovary cell). The in vivo antitumor effect showed that the Dox-loaded
DNA nanostructure was more effective in prohibition of the
tumor growth compared to free Dox. These findings showed that the Dox-loaded three-way junction pocket
DNA nanostructure could significantly reduce the cytotoxic effects of Dox against nontarget cells.